Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs 1,839
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Pipeline programs

Page 1 of 39

  1. "Nefecon®","Ambrisentan"

    The First People's Hospital of Lianyungang

    IgA Nephropathy

    approved small molecule active

    1 trial

  2. "Nycoplus Magnesium" (120 mg x 3 daily for 2 weeks)

    Takeda

    Cramps

    approved small molecule completed

    1 trial

  3. -

    The George Institute

    Acute lower Respiratory Tract Infection or acute rhinosinusitis

    approved small molecule active

    1 trial

  4. 0.1% bromfenac

    Zhongshan Ophthalmic Center, Sun Yat-sen University

    Pterygium

    approved small molecule completed

    1 trial

  5. 0.1% bupivacaine

    United Therapeutics Europe Ltd

    Pregnancy

    approved small molecule active

    1 trial

  6. 0.3% ropivacaine and 50 μg dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Free Flap Reconstruction

    approved small molecule active

    1 trial

  7. 0.33% ropivacaine 250ml

    Guangzhou General Hospital of Guangzhou Military Command

    Pain

    approved small molecule completed

    1 trial

  8. 0.9% Sodium Chloride Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Unstable Angina

    approved small molecule active

    1 trial

  9. 002-2019

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use

    approved small molecule completed

    1 trial

  10. 050901

    Takeda

    Hemophilia B

    approved mab completed

    1 trial

  11. 060201

    Takeda

    Hemophilia A

    approved small molecule completed

    6 trials

  12. 1-84 parathyroid hormone

    Takeda

    Shoulder Fractures

    approved small molecule active

    1 trial

  13. 100mg SPN-812

    SUPERNUS PHARMACEUTICALS, INC.

    Attention-Deficit/Hyperactivity Disorder

    approved small molecule active

    1 trial

  14. 103900

    Disc Medicine

    HIV-infected

    approved small molecule active

    1 trial

  15. 112771

    Disc Medicine

    Fungal infection

    approved small molecule active

    1 trial

  16. 114180

    Disc Medicine

    Stroke

    approved small molecule active

    1 trial

  17. 115

    Chinese University of Hong Kong

    Essential Hypertension

    approved small molecule active

    1 trial

  18. 115083

    Disc Medicine

    Dystonic tremor syndrome

    approved small molecule active

    1 trial

  19. 116795

    Disc Medicine

    Type 1 Diabetes

    approved small molecule active

    1 trial

  20. 16 mg buprenorphine with 4 mg naloxone sublingual film

    Teva Pharma GmbH

    Evaluation of QTc Interval

    approved other terminated

    1 trial

  21. 16995

    Regeneron UK Limited

    Neovascular Macular Degeneration

    approved small molecule completed

    1 trial

  22. 17508

    Regeneron UK Limited

    Macular Degeneration

    approved small molecule completed

    1 trial

  23. 17668

    Regeneron UK Limited

    Wet Macular Degeneration

    approved small molecule completed

    1 trial

  24. 18253

    Disc Medicine

    Albuminuria, Type 2 diabetes

    approved small molecule active

    1 trial

  25. 1838-009

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule terminated

    1 trial

  26. 19-659

    Disc Medicine

    Carotid artery stenosis

    approved small molecule active

    1 trial

  27. 2 doses of HAV

    Sinovac Research and Development Co.,

    Hepatitis A

    approved mab completed

    1 trial

  28. 2.0mg Buprenorphine/0.5mg Naloxone

    Indivior Pty Ltd

    Hepatic Failure

    approved small molecule completed

    1 trial

  29. 20061016-V2

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other terminated

    1 trial

  30. 2010-279-12

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    approved small molecule completed

    1 trial

  31. 201010025M

    Hospital Authority, Hong Kong

    Hepatitis

    approved small molecule active

    1 trial

  32. 2012-2013 trivalent seasonal influenza vaccine

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  33. 201305128

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  34. 2018ZX10721202001002001

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B Vaccine

    approved mab active

    3 trials

  35. 202000842

    Disc Medicine

    Depression

    approved small molecule active

    1 trial

  36. 20220159

    Amgen

    Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)

    approved small molecule active

    1 trial

  37. 2024-515363-63-00

    Disc Medicine

    Asplenia

    approved small molecule active

    1 trial

  38. 2024-517043-32-00

    Disc Medicine

    Post Transplantation Patients

    approved small molecule active

    1 trial

  39. 2024-517112-30-00

    Disc Medicine

    Rheumatoid arthritis

    approved small molecule active

    1 trial

  40. 2024/3873 CABOLD

    The George Institute

    Renal carcinoma

    approved small molecule active

    1 trial

  41. 2025101109

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Allergic Rhinitis

    approved small molecule active

    1 trial

  42. 20510

    Bayer AG

    metastatic castrate resistant prostate cancer (mCRPC)

    approved small molecule active

    1 trial

  43. 20725

    Disc Medicine

    Chronic Kidney disease

    approved small molecule active

    1 trial

  44. 20mg Febuxostat

    The First People's Hospital of Lianyungang

    Hyperuricemia

    approved small molecule active

    1 trial

  45. 219815

    GlaxoSmithKline

    Respiratory Syncytial Virus Infections

    approved small molecule active

    1 trial

  46. 219871

    GlaxoSmithKline

    severe asthma

    approved small molecule active

    1 trial

  47. 22-571/21U-0151

    Disc Medicine

    Congenital Haemophilia A

    approved small molecule active

    1 trial

  48. 220901

    Takeda

    Prothrombin Complex Factor Deficiency

    approved mab completed

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.